Stage II in the development of Eph/ephrin based tumor targeting reagents: optimisation of drug efficacy and delivery

  • Lackmann, Martin (Primary Chief Investigator (PCI))
  • Boyd, Andrew (Chief Investigator (CI))
  • Scott, Andrew (Chief Investigator (CI))
  • Treutlein, Herbert (Chief Investigator (CI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/07/0430/06/05

Funding

  • National Health & Medical Research Council (NHMRC): AUD204,125.00